We previously identified HER2 and CXCR4 as possible alternative targets in the treatment of esophageal carcinoma and associated mild hypoxia leading to expression of CAIX with increased metastatic spread [2,22,23,24,25]. Here, ERBB2 is linked to carcinoma of esophagus.